Immuron IMRN
NASDAQ IMRN
$1.22 +0.04 (+3.39%)
At close: Sep 18, 2026 · 4:00 PM EDT

Immuron (IMRN) Equity Income (2022 - 2024)

Immuron (IMRN) posted Equity Income of -$9702.0 for Q3 2024, up 98.99% on a QoQ basis from -$959552.2 in Q2 2024.

Analysis

Immuron (IMRN) Equity Income (2022 - 2024) Analysis & Trends

Immuron has reported Equity Income for 3 years, with the latest figure at -$9702.0 in Q3 2024.

  • On a quarterly basis, Equity Income changed N/A year-over-year to -$9702.0 in Q3 2024; TTM through Sep 2024 was -$1.3 million, a N/A change from a year earlier, with the FY2024 full-year figure at -$14560.2, up 92.82% from the prior year.
  • Equity Income was -$9702.0 for Q3 2024 at Immuron, up from -$959552.2 in the prior quarter.
  • The five-year high for Equity Income was -$9702.0 in Q3 2024, with the low at -$959552.2 in Q2 2024.
  • Average Equity Income over 3 years is -$318033.1, with a median of -$151439.1 recorded in 2023.
  • The largest YoY upside for Equity Income was 130.16% in 2023 against a maximum downside of 130.16% in 2023.
  • Over 3 years, Equity Income stood at -$91736.0 in 2022, then plunged by 130.16% to -$211142.3 in 2023, then surged by 95.41% to -$9702.0 in 2024.
  • The last three Equity Income figures came in at -$9702.0 (Q3 2024), -$959552.2 (Q2 2024), and -$211142.3 (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn -
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn -
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -
10 Immuron 7.14 Mn -1.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 9, 2024 -9,701.96
Jun 30, 2024 -959,552.17
Dec 31, 2023 -211,142.25
Dec 31, 2022 -91,736.00